AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 159 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $569 | -12.6% | 23 | 0.0% | 0.00% | – |
| Q2 2023 | $651 | – | 23 | +475.0% | 0.00% | – |
| Q3 2022 | $0 | – | 4 | -55.6% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 9 | -83.0% | 0.00% | – |
| Q3 2021 | $2,000 | -50.0% | 53 | -25.4% | 0.00% | – |
| Q2 2021 | $4,000 | -42.9% | 71 | -49.3% | 0.00% | – |
| Q1 2021 | $7,000 | +75.0% | 140 | +37.3% | 0.00% | – |
| Q4 2020 | $4,000 | -85.2% | 102 | -86.7% | 0.00% | -100.0% |
| Q3 2020 | $27,000 | -67.5% | 768 | -50.8% | 0.00% | -60.0% |
| Q2 2020 | $83,000 | +2666.7% | 1,562 | +1510.3% | 0.01% | – |
| Q1 2020 | $3,000 | -57.1% | 97 | -29.2% | 0.00% | -100.0% |
| Q4 2019 | $7,000 | +600.0% | 137 | +341.9% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 31 | +6.9% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 29 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | – | 29 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |